Kura Oncology KURA
NASDAQ KURA
$7.73 +0.16 (+2.11%)
At close: Nov 11, 2026 · 4:00 PM EST

Kura Oncology (KURA) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Kura Oncology's Net Equity Issued and Repurchased came in at $1.5 million for Q2 2026, up 191.1% from $515,000 a year earlier.

Analysis

Kura Oncology (KURA) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kura Oncology reported Net Equity Issued and Repurchased of $2.7 million, down 26.3% year-over-year; for FY2025, it was $1.79 million, down 79.2% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -67.0% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $8.6 million in FY2024 (+613.4%), $1.21 million in FY2023 (-72.7%), $4.42 million in FY2022 (-0.2%) and $4.43 million in FY2021 (-99.0%).
  • The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q3 2024.
  • Year-over-year, Net Equity Issued and Repurchased increased in three of the last six quarters, with growth averaging 3.2%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2022 (growth of 389.7%), and the weakest in Q4 2021 (a decline of 99.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kura Oncology 695.52 Mn -1.56 Bn 22.47 Mn 32.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 32.54 Mn
Jun 30, 2026 1.50 Mn
Mar 31, 2026 69,000.00
Dec 31, 2025 1.14 Mn
Jun 30, 2025 515,000.00
Mar 31, 2025 143,000.00
Dec 31, 2024 806,000.00
Sep 30, 2024 2.20 Mn
Jun 30, 2024 3.04 Mn
Mar 31, 2024 148.37 Mn
Dec 31, 2023 691,000.00
Dec 31, 2022 25.29 Mn
Sep 30, 2022 880,000.00
Jun 30, 2022 2.67 Mn
Mar 31, 2022 303,000.00
Dec 31, 2021 794,000.00
Sep 30, 2021 2.26 Mn
Jun 30, 2021 545,000.00
Mar 31, 2021 829,000.00
Dec 31, 2020 327.29 Mn
API Access

Kura Oncology Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KURA&period=max&api_key=YOUR_API_KEY